This issue of the Communicable disease threats report (CDTR) covers the period 10 - 16 October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, Ebola, expert deployment, pneumonia of unknown aetiology, mpox in the EU/EEA, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, and diphtheria.
Communicable disease threats report, 10 - 16 October, week 42
English (2.67 MB - PDF)
A three-day training workshop organised by ECDC and WHO/Europe and hosted by the Slovenian National Institute of Public Health (NIPH) brought together participants from the EU and a number of accession countries to strengthen their national Public Health Emergency Operations Centres (PHEOCs) and to ensure they operate in line with EU and international standards.
In the EU/EEA, SARS-CoV-2 circulation remains low, although higher rates in two countries are affecting the overall picture. Respiratory syncytial virus and influenza circulation remain at low levels.
This report gives an overview of the countries and areas where dengue cases – and their corresponding case numbers - have been reported to the European surveillance portal for infectious diseases (EpiPulse).
Update providing weekly overview of the countries and areas where chikungunya virus disease cases have been reported.
Dashboard showing the countries that still have remaining cases of WPV, and also those with cases of circulating vaccine derived polio virus (cVPDV).
Weekly updates with the latest reports on West Nile virus cases in Europe updated every Friday, during the transmission season.
Weekly updated overview of reported Crimean-Congo haemorrhagic fever (CCHF) in the EU/EEA countries and areas.
Detailed information on plague for healthcare professionals.
With the EU experiencing its most intense West Nile virus season to date and detections of the virus in new areas further north in Europe, ECDC calls for sustained prevention, surveillance and mosquito control.
Monthly updates with the latest reports on West Nile virus cases in Europe.
Since May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).
This report presents data on mpox cases reported to the European Surveillance System (EpiPulse Cases). EU/EEA countries report case based data to ECDC on diagnosed mpox cases. For case numbers by countries, Western Balkans and Türkiye are included.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
The primary EU-level public health objective of the CRECC pilot survey is to determine the occurrence, geographical distribution and population dynamics of high-risk CRECC lineages, and related transmissible genetic elements of public health importance, within healthcare settings in Europe to improve risk assessment and control policies.
Protocol for the carbapenem-resistant Enterobacter cloacae complex (CRECC) pilot survey
English (837.6 KB - PDF)
The aim of the Public Health Emergency Preparedness Assessment, as mandated in Article 8 of Regulation (EU) 2022/2371 on serious cross-border threats to health, is to improve prevention, preparedness and response planning in European Union/European Economic Area (EU/EEA) countries through the implementation of recommendations following individual country assessments.
Country report: ECDC Public Health Emergency Preparedness Assessment for the Czech Republic, 2026
English (1.04 MB - PDF)
This handbook provides laboratory professionals in the EU/EEA with a comprehensive overview of commonly used laboratory protocols for the characterisation of respiratory syncytial virus (RSV).
Handbook of laboratory protocols for respiratory syncytial virus (RSV) characterisation
English (2.46 MB - PDF)
This issue of the Communicable disease threats report (CDTR) covers the period 3 - 9October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, pneumonia of unknown aetiology, Ebola, expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, symptomatic Sindbis case in Germany, measles, and Salmonella Strathcona.
Communicable disease threats report, 3 - 9 October, week 41
English (2.64 MB - PDF)
In the EU/EEA, increased circulation of SARS-CoV-2 is observed, with limited impact on hospitalisations. Respiratory syncytial virus and influenza circulation remain at low levels.
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
West Nile virus (WNV) infection is a mosquito-borne zoonosis that is endemo-epidemic in Europe.
Highly pathogenic avian influenza A(H5N1) continues to circulate widely in wild birds and cause outbreaks in poultry and other animals across Europe. Despite extensive circulation, human infections remain rare and no human cases have been confirmed in the EU/EEA to date.
Zoonotic influenza A(H5) vaccination in humans in the EU/EEA
English (735.12 KB - PDF)